** Medical imaging software provider Pro Medicus PME.AX gains 1.6% to A$257.85; set for its biggest intraday pct gain since Jan. 9
** Jefferies retains "hold"; raises PT to A$250
** Says co can secure significant earnings growth despite lofty ~A$250/shr valuation, implying 98% U.S. radiology market penetration and demanding near-total market dominance for support
** Revises FY26-27 earnings to 13%-32% ahead of consensus; sees fair value of PME at A$140, implying ~50% U.S. market share
** Says existing customers, such as NYU Langone and Duke University, upgrading to full range of services may boost rev by 24%
** Adds PME's Visage viewer tech outshines newly launched DeepHealth OS Fast Viewer by California-based Radnet RDNT.O
** Stock rated "hold" on avg; median PT is A$237.50 – LSEG
** PME more than doubled in value last year, gaining 161%
(Reporting by Kumar Tanishk in Bengaluru)
((Tanishk.Kumar@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.